Skip to main content
EJNMMI Research
Fig. 5 | EJNMMI Research

Fig. 5

From: Prospective comparison of [18F]AlF-NOTA-octreotide PET/MRI to [68Ga]Ga-DOTATATE PET/CT in neuroendocrine tumor patients

Fig. 5

Transverse PET images with A [18F]AlF-OC and C [68Ga]Ga-DOTATATE showing a concordant liver lesion (blue arrow) and an incremental liver lesion with [18F]AlF-OC (green arrow). B DWI MRI shows a corresponding lesion for both liver lesions and therefore confirms the incremental lesion. D [68Ga]Ga-DOTATATE PET 6 months later also shows the incremental liver lesion (orange arrow)

Back to article page